Growth Metrics

Labcorp Holdings (LH) Current Deferred Revenue (2016 - 2025)

Labcorp Holdings (LH) has disclosed Current Deferred Revenue for 11 consecutive years, with $439.1 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 11.96% to $439.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $439.1 million through Dec 2025, up 11.96% year-over-year, with the annual reading at $439.1 million for FY2025, 11.96% up from the prior year.
  • Current Deferred Revenue hit $439.1 million in Q4 2025 for Labcorp Holdings, up from $391.6 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $593.9 million in Q3 2021 to a low of $310.6 million in Q4 2022.
  • Historically, Current Deferred Revenue has averaged $453.9 million across 5 years, with a median of $412.4 million in 2023.
  • Biggest five-year swings in Current Deferred Revenue: crashed 44.39% in 2022 and later surged 35.77% in 2023.
  • Year by year, Current Deferred Revenue stood at $558.5 million in 2021, then plummeted by 44.39% to $310.6 million in 2022, then soared by 35.77% to $421.7 million in 2023, then dropped by 7.0% to $392.2 million in 2024, then grew by 11.96% to $439.1 million in 2025.
  • Business Quant data shows Current Deferred Revenue for LH at $439.1 million in Q4 2025, $391.6 million in Q3 2025, and $398.0 million in Q2 2025.